Bellicum

Developer of T cell therapies for the treatment of cancer and chronic infectious diseases

placeHouston, Texas, United States calendar_todayFounded 2004 groups108 employees language bellicum.com

Registered entities

Investor mix

17 investors on record; lead investors include Jennison, RA Capital Management, VenBio, Perceptive Advisors.

Investor typeCountShare
Venture capital847%
Private equity212%
Bank & private debt16%
Other / undisclosed635%
Coming soon